Funds with similar focus
Fund Name | Location |
AIB Equity | County Dublin, Dublin, Ireland |
Beijing Guoyou Ziben | Beijing, Beijing, China |
Bering Waters Ventures | - |
Bravia Capital | China, Hong Kong, Hong Kong Island |
Brigus Capital | Canada, Halifax, Nova Scotia |
City & Guilds Group New Venture Fund | - |
Datran Media | New York, New York, United States |
EMJ Ventures | - |
Hendale Capital | China, Hong Kong, Hong Kong Island |
Invicta Growth | Amsterdam, Noord-Holland, The Netherlands |
Midana Capital | China, Hong Kong, Hong Kong Island |
North Coast Venture Fund | - |
Plaridel Ltd | - |
Rarestone Capital | - |
Sanquan Foods | China, Henan, Zhengzhou |
Simplex Holdings | Japan, Tokyo |
Valley Oak Investments | California, San Francisco, United States |
Zhonghong Gold Control | Beijing, Beijing Shi, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Hope Medicine | $30M | 07 Feb 2024 | Xuanwu District, Jiangsu, China | ||
Laiye | $70M | 18 Apr 2022 | Dongcheng District, Beijing, China | ||
Uniskin | $15M | 01 Dec 2021 | Shanghai, Shanghai, China | ||
HAI ROBOTICS | $30M | 21 Sep 2021 | Shenzhen, Guangdong, China | ||
Inmagene Biopharmaceuticals | $100M | 01 Jun 2021 | Zhangdian District, Shandong, China | ||
Bliss Biopharmaceutical (Hangzhou) Co., Ltd. | $61M | 16 Apr 2021 | - | ||
Chime Biologics | $190M | 25 Mar 2021 | Jiang'an District, Hubei, China | ||
Didi Freight | $1B | 14 Jan 2021 | Beijing, Beijing, China | ||
Dingdong Maicai | 25 Jul 2019 | China, Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Hope Medicine | $30M | 07 Feb 2024 | Xuanwu District, Jiangsu, China | ||
Laiye | $70M | 18 Apr 2022 | Dongcheng District, Beijing, China | ||
Uniskin | $15M | 01 Dec 2021 | Shanghai, Shanghai, China | ||
HAI ROBOTICS | $30M | 21 Sep 2021 | Shenzhen, Guangdong, China | ||
Inmagene Biopharmaceuticals | $100M | 01 Jun 2021 | Zhangdian District, Shandong, China | ||
Bliss Biopharmaceutical (Hangzhou) Co., Ltd. | $61M | 16 Apr 2021 | - | ||
Chime Biologics | $190M | 25 Mar 2021 | Jiang'an District, Hubei, China | ||
Didi Freight | $1B | 14 Jan 2021 | Beijing, Beijing, China | ||
Dingdong Maicai | 25 Jul 2019 | China, Shanghai |